These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

154 related articles for article (PubMed ID: 31547271)

  • 21. Characteristics of patients and patterns of chronic venous disease of the lower limbs in a referral hospital in Cameroon.
    Fokou M; Moifo B; Fongang E; Teyang A; Muna W
    J Vasc Surg Venous Lymphat Disord; 2018 Jan; 6(1):90-95. PubMed ID: 29097175
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Quality of live as measured by the CIVQ 20. Questionnaire following oral mesoglycan treatment of patients with chronic venous disease.
    Allegra C; Antignani PL
    Int Angiol; 2014 Oct; 33(5):407-18. PubMed ID: 24566500
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Micronised purified flavonoid fraction: a review of its use in chronic venous insufficiency, venous ulcers and haemorrhoids.
    Lyseng-Williamson KA; Perry CM
    Drugs; 2003; 63(1):71-100. PubMed ID: 12487623
    [TBL] [Abstract][Full Text] [Related]  

  • 24. The combination of intermediate doses of thalidomide and dexamethasone reduces bone marrow micro-vessel density but not serum levels of angiogenic cytokines in patients with refractory/relapsed multiple myeloma.
    Hatjiharissi E; Terpos E; Papaioannou M; Hatjileontis C; Kaloutsi V; Galaktidou G; Gerotziafas G; Christakis J; Zervas K
    Hematol Oncol; 2004 Dec; 22(4):159-68. PubMed ID: 15991268
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Analysis of vascular endothelial growth factor gene expression in the tissues of patients with chronic venous insufficiency.
    Flórez A; De Haro J; Bleda S; Varela C; Esparza L; Acin F
    Phlebology; 2013 Feb; 28(1):32-7. PubMed ID: 22368191
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Influence of Diosmin Treatment on the Level of Oxidative Stress Markers in Patients with Chronic Venous Insufficiency.
    Feldo M; Woźniak M; Wójciak-Kosior M; Sowa I; Kot-Waśik A; Aszyk J; Bogucki J; Zubilewicz T; Bogucka-Kocka A
    Oxid Med Cell Longev; 2018; 2018():2561705. PubMed ID: 30228853
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Malignant ascites fluid (MAF), including ovarian-cancer-associated MAF, contains angiostatin and other factor(s) which inhibit angiogenesis.
    Richardson M; Gunawan J; Hatton MW; Seidlitz E; Hirte HW; Singh G
    Gynecol Oncol; 2002 Sep; 86(3):279-87. PubMed ID: 12217749
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Vascular endothelial growth factor (VEGF)-C synergizes with basic fibroblast growth factor and VEGF in the induction of angiogenesis in vitro and alters endothelial cell extracellular proteolytic activity.
    Pepper MS; Mandriota SJ; Jeltsch M; Kumar V; Alitalo K
    J Cell Physiol; 1998 Dec; 177(3):439-52. PubMed ID: 9808152
    [TBL] [Abstract][Full Text] [Related]  

  • 29. [Drug-mediated correction of negative phlebotropic effects of hormone replacement therapy in women].
    Tsukanov IuT; Tsukanov AIu; Bazhenov VN; Kornienko IF; Vasilevich VV
    Angiol Sosud Khir; 2009; 15(3):87-91. PubMed ID: 20092188
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Recommendations for the medical management of chronic venous disease: The role of Micronized Purified Flavanoid Fraction (MPFF).
    Bush R; Comerota A; Meissner M; Raffetto JD; Hahn SR; Freeman K
    Phlebology; 2017 Apr; 32(1_suppl):3-19. PubMed ID: 28211296
    [TBL] [Abstract][Full Text] [Related]  

  • 31. A reduction in serum cytokine levels parallels healing of venous ulcers in patients undergoing compression therapy.
    Murphy MA; Joyce WP; Condron C; Bouchier-Hayes D
    Eur J Vasc Endovasc Surg; 2002 Apr; 23(4):349-52. PubMed ID: 11991698
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Mesalamine restores angiogenic balance in experimental ulcerative colitis by reducing expression of endostatin and angiostatin: novel molecular mechanism for therapeutic action of mesalamine.
    Deng X; Tolstanova G; Khomenko T; Chen L; Tarnawski A; Szabo S; Sandor Z
    J Pharmacol Exp Ther; 2009 Dec; 331(3):1071-8. PubMed ID: 19762547
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Differential effects of vascular growth factors on arterial and venous angiogenesis.
    Blebea J; Vu JH; Assadnia S; McLaughlin PJ; Atnip RG; Zagon IS
    J Vasc Surg; 2002 Mar; 35(3):532-8. PubMed ID: 11877704
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Quantitative expression of serum biomarkers involved in angiogenesis and inflammation, in patients with glioblastoma multiforme: correlations with clinical data.
    Chiorean R; Berindan-Neagoe I; Braicu C; Florian IS; Leucuta D; Crisan D; Cernea V
    Cancer Biomark; 2014; 14(2-3):185-94. PubMed ID: 24878820
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Inhibition of vascular endothelial growth factor-mediated neointima progression with angiostatin or paclitaxel.
    Celletti FL; Waugh JM; Amabile PG; Kao EY; Boroumand S; Dake MD
    J Vasc Interv Radiol; 2002 Jul; 13(7):703-7. PubMed ID: 12119329
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Selected growth factors in peritoneal dialysis: their relationship to markers of inflammation, dialysis adequacy, residual renal function, and peritoneal membrane transport.
    Stompór T; Zdzienicka A; Motyka M; Dembińska-Kieć A; Davies SJ; Sulowicz W
    Perit Dial Int; 2002; 22(6):670-6. PubMed ID: 12556068
    [TBL] [Abstract][Full Text] [Related]  

  • 37. [Effect of statin therapy on dynamics of vascular endothelial growth factor and fibroblast growth factor in patients with ischemic heart disease].
    Sergienko IV; Semenova AE; Masenko VP; Ezhov MV; Gabrusenko SA; Kukharchuk VV; Belenkov IuN
    Kardiologiia; 2007; 47(8):4-7. PubMed ID: 18260902
    [TBL] [Abstract][Full Text] [Related]  

  • 38. The influence of rosuvastatin therapy and percutaneous coronary intervention on angiogenic growth factors in coronary artery disease patients.
    Semenova AE; Sergienko IV; Masenko VP; Ezhov MV; Gabrusenko SA; Kuharchuk VV; Belenkov YN
    Acta Cardiol; 2009 Jun; 64(3):405-9. PubMed ID: 19593954
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Effect of ultrasound on the production of IL-8, basic FGF and VEGF.
    Reher P; Doan N; Bradnock B; Meghji S; Harris M
    Cytokine; 1999 Jun; 11(6):416-23. PubMed ID: 10346981
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Platelet number and interleukin-6 correlate with VEGF but not with bFGF serum levels of advanced cancer patients.
    Salgado R; Vermeulen PB; Benoy I; Weytjens R; Huget P; Van Marck E; Dirix LY
    Br J Cancer; 1999 May; 80(5-6):892-7. PubMed ID: 10360671
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.